237 related articles for article (PubMed ID: 34711980)
1. Selective G protein signaling driven by substance P-neurokinin receptor dynamics.
Harris JA; Faust B; Gondin AB; Dämgen MA; Suomivuori CM; Veldhuis NA; Cheng Y; Dror RO; Thal DM; Manglik A
Nat Chem Biol; 2022 Jan; 18(1):109-115. PubMed ID: 34711980
[TBL] [Abstract][Full Text] [Related]
2. Heterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors.
Schmidlin F; Déry O; Bunnett NW; Grady EF
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3324-9. PubMed ID: 11880656
[TBL] [Abstract][Full Text] [Related]
3. Structures of neurokinin 1 receptor in complex with G
Thom C; Ehrenmann J; Vacca S; Waltenspühl Y; Schöppe J; Medalia O; Plückthun A
Sci Adv; 2021 Dec; 7(50):eabk2872. PubMed ID: 34878828
[TBL] [Abstract][Full Text] [Related]
4. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
5. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.
Jensen DD; Lieu T; Halls ML; Veldhuis NA; Imlach WL; Mai QN; Poole DP; Quach T; Aurelio L; Conner J; Herenbrink CK; Barlow N; Simpson JS; Scanlon MJ; Graham B; McCluskey A; Robinson PJ; Escriou V; Nassini R; Materazzi S; Geppetti P; Hicks GA; Christie MJ; Porter CJH; Canals M; Bunnett NW
Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566424
[TBL] [Abstract][Full Text] [Related]
6. Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons.
Taylor BK; Fu W; Kuphal KE; Stiller CO; Winter MK; Chen W; Corder GF; Urban JH; McCarson KE; Marvizon JC
Neuroscience; 2014 Jan; 256():178-94. PubMed ID: 24184981
[TBL] [Abstract][Full Text] [Related]
7. Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.
Schmidlin F; Dery O; DeFea KO; Slice L; Patierno S; Sternini C; Grady EF; Bunnett NW
J Biol Chem; 2001 Jul; 276(27):25427-37. PubMed ID: 11306580
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.
Jensen DD; Halls ML; Murphy JE; Canals M; Cattaruzza F; Poole DP; Lieu T; Koon HW; Pothoulakis C; Bunnett NW
J Biol Chem; 2014 Jul; 289(29):20283-94. PubMed ID: 24898255
[TBL] [Abstract][Full Text] [Related]
9. Biased Gs versus Gq proteins and β-arrestin signaling in the NK1 receptor determined by interactions in the water hydrogen bond network.
Valentin-Hansen L; Frimurer TM; Mokrosinski J; Holliday ND; Schwartz TW
J Biol Chem; 2015 Oct; 290(40):24495-508. PubMed ID: 26269596
[TBL] [Abstract][Full Text] [Related]
10. Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases.
Roosterman D; Cottrell GS; Schmidlin F; Steinhoff M; Bunnett NW
J Biol Chem; 2004 Jul; 279(29):30670-9. PubMed ID: 15128739
[TBL] [Abstract][Full Text] [Related]
11. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin-1 Receptor Signaling Is Required for Efficient Ca
Morelli AE; Sumpter TL; Rojas-Canales DM; Bandyopadhyay M; Chen Z; Tkacheva O; Shufesky WJ; Wallace CT; Watkins SC; Berger A; Paige CJ; Falo LD; Larregina AT
Cell Rep; 2020 Mar; 30(10):3448-3465.e8. PubMed ID: 32160549
[TBL] [Abstract][Full Text] [Related]
13. Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R.
Chakraborty S; Nepiyushchikh Z; Davis MJ; Zawieja DC; Muthuchamy M
Microcirculation; 2011 Jan; 18(1):24-35. PubMed ID: 21166923
[TBL] [Abstract][Full Text] [Related]
14. Divergent β-arrestin-dependent signaling events are dependent upon sequences within G-protein-coupled receptor C termini.
Pal K; Mathur M; Kumar P; DeFea K
J Biol Chem; 2013 Feb; 288(5):3265-74. PubMed ID: 23235155
[TBL] [Abstract][Full Text] [Related]
15. Substance P enhances the local activation of NK
Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W
BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655
[TBL] [Abstract][Full Text] [Related]
16. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses.
Sumpter TL; Ho CH; Pleet AR; Tkacheva OA; Shufesky WJ; Rojas-Canales DM; Morelli AE; Larregina AT
J Allergy Clin Immunol; 2015 Apr; 135(4):1019-1030.e8. PubMed ID: 25201259
[TBL] [Abstract][Full Text] [Related]
17. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
Koh YH; Moochhala S; Bhatia M
J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
[TBL] [Abstract][Full Text] [Related]
18. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Ebrahimi S; Javid H; Alaei A; Hashemy SI
Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
[TBL] [Abstract][Full Text] [Related]
19. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.
Douglas SD; Lai JP; Tuluc F; Schwartz L; Kilpatrick LE
Ann N Y Acad Sci; 2008 Nov; 1144():90-6. PubMed ID: 19076368
[TBL] [Abstract][Full Text] [Related]
20. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi
Suthiram J; Pieters A; Mohamed Moosa Z; Zeevaart JR; Sathekge MM; Ebenhan T; Anderson RC; Newton CL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
